HEMOLYTIC PROPERTIES OF PLURONIC SURFACTANTS AND EFFECTS OF PURIFICATION

被引:20
作者
LOWE, KC
FURMIDGE, BA
THOMAS, S
机构
[1] Department of Life Science, University of Nottingham, University Park
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY | 1995年 / 23卷 / 01期
关键词
D O I
10.3109/10731199509117673
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The effects of incubating blood from mice, rats, rabbits or hamsters with either a commercial grade or a silica-purified fraction of Pluronic F-68 or Pluronic F-38 have been studied. Incubation of blood with up to 4.0% (w/v) of commercial or purified Pluronic F-68 produced no detectable haemolysis (< 0.1%). Haemolysis did occur with concentrations of commercial Pluronic F-68 above 4.0% (w/v). This was maximal with rat blood incubated with 10.0% (w/v) Pluronic F-68, where the mean haemolysis was 4.7 +/- 1.5%; the mean haemolysis in rat blood was reduced to 0.5 +/- 0.3% (P < 0.05) following incubation with the purified Pluronic F-68 fraction. Neither commercial grade or purified Plutonic F-38 produced any significant haemolysis when incubated with rat or hamster blood. Incubation of rabbit blood with 10.O% (w/v) commercial Pluronic F-38 produced only 0.5% haemolysis.
引用
收藏
页码:135 / 139
页数:5
相关论文
共 15 条
[1]  
AL-ASSADI H M T, 1990, Journal of Pharmacy and Pharmacology, V42, p161P
[2]   PURIFICATION OF PLURONIC F-68 FOR PERFLUOROCHEMICAL EMULSIFICATION [J].
BENTLEY, PK ;
DAVIS, SS ;
JOHNSON, OL ;
LOWE, KC ;
WASHINGTON, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1989, 41 (09) :661-663
[3]  
CARTER C, 1992, CLIN HEMORHEOL, V12, P109
[4]  
GROVER FL, 1969, CIRCULATION S1, V39, P1
[5]  
KHO BT, 1979, QUANTITATIVE ORGANIC, P295
[6]  
KNIZE DM, 1969, SURG GYNECOL OBSTETR, V129, P1019
[7]   YEAST PERMEABILIZATION WITH SURFACTANTS [J].
LAOUAR, L ;
MULLIGAN, BJ ;
LOWE, KC .
BIOTECHNOLOGY LETTERS, 1992, 14 (08) :719-720
[8]  
Lowe K. C., 1993, Agro Food Industry Hi-Tech, V4, P9
[9]  
LOWE KC, 1992, CLIN HEMORHEOL, V12, P141
[10]  
Lowe KC, 1994, VASC MED REV, V5, P15